Medscape InDiscussion: Multiple Myeloma

Listen to Medscape InDiscussion: Multiple Myeloma, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/964336. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Medscape InDiscussion: Multiple Myeloma is a science podcast hosted by Medscape, with 12 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Medscape hosts Medscape InDiscussion: Multiple Myeloma, a science show with 12 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #6

  What Is the Future of Multiple Myeloma?

  Dec 18, 202525 minS2

  <p>Drs Joseph Mikhael and Shaji Kumar discuss the future of multiple myeloma, including enhanced diagnostics for detecting myeloma, frontline therapy, and durable responses.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002718. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p>Resources</p> <p>Multiple Myeloma https://emedicine.medscape.com/article/204369-overview</p> <p>Updated Diagnostic Criteria and Staging System for Multiple Myeloma https://pubmed.ncbi.nlm.nih.gov/27249749/</p> <p>Mass Spectrometry for the...

  ListenShow Notes
• 

  Episode #5

  Is It Time to Screen for Multiple Myeloma?

  Nov 20, 202523 minS2

  <p>Drs Joseph Mikhael and Sigurdur Y. Kristinsson discuss whether it is time to screen for multiple myeloma and what we can learn from the iStopMM study.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002717. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p>Resources</p> <p>Multiple Myeloma https://emedicine.medscape.com/article/204369-overview</p> <p>Screening in Multiple Myeloma and Its Precursors: Are We There Yet? https://pubmed.ncbi.nlm.nih.gov/38175579/</p> <...

  ListenShow Notes
• 

  Episode #4

  Should You Treat Smoldering Multiple Myeloma?

  Oct 22, 202525 minS2

  <p>Drs Joseph Mikhael and Peter Voorhees discuss considerations for treating smoldering multiple myeloma, including recent studies and shared decision-making.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002716. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p>Resources</p> <p>Observation or Treatment for Smoldering Multiple Myeloma? A Systematic Review and Meta-Analysis of Randomized Controlled Studies https://pubmed.ncbi.nlm.nih.gov/40419473/</p> <p>Monoclonal Gammopathy of Undetermined Significance https://www.ncbi.nlm.nih.gov...

  ListenShow Notes
• 

  Episode #3

  When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?

  Sep 23, 202525 minS2

  <p>Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p>Resources</p> <p>Multiple Myeloma https://emedicine.medscape.com/article/204369-overview</p> <p>CARTITUDE-1 Final Results: Phase 1b/2 Study of Ciltacabtagene Autoleucel in Heavily Pretreated Patients With Relapsed/Refractory Multiple Myeloma https://ascopubs...

  ListenShow Notes
• 

  Episode #2

  Should All Newly Diagnosed Multiple Myeloma Patients Be Treated With a Quadruplet in Frontline Therapy?

  Aug 21, 202524 minS2

  <p>Drs Joseph Mikhael and Saad Usmani discuss why quadruplet therapy is now the new standard of care for treating newly diagnosed multiple myeloma patients.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002714. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p>Resources</p> <p>Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma https://pubmed.ncbi.nlm.nih.gov/38084760/</p> <p>Isatuximab, Lenalidomide, Dexamethasone and Bortezomib in Transplant-Ineligible Multiple Myeloma: The Randomized Phase 3 BENEFIT Trial...

  ListenShow Notes

Recent guests on Medscape InDiscussion: Multiple Myeloma. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.